Important Notice: Our web hosting provider recently started charging us for additional visits, which was unexpected. In response, we're seeking donations. Depending on the situation, we may explore different monetization options for our Community and Expert Contributors. It's crucial to provide more returns for their expertise and offer more Expert Validated Answers or AI Validated Answers. Learn more about our hosting issue here.
The National Cancer Institute-sponsored Working Group (NCI-WG) on chronic lymphocytic leukemia (CLL) has published guidelines for the design and conduct of clinical trials in CLL with the objective to facilitate comparisons of results of these trials by providing standardized eligibility, response and toxicity criteria.
